4.5 Article

A systems-level analysis highlights microglial activation as a modifying factor in common epilepsies

Journal

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
Volume 48, Issue 1, Pages -

Publisher

WILEY
DOI: 10.1111/nan.12758

Keywords

cortical thinning; gene expression; MRI; post mortem

Funding

  1. Medical Research Council eMedLab Medical Bioinformatics Career Development Fellowship
  2. Medical Research Council [MR/L016311/1]
  3. Medical Research Council Clinician Scientist Fellowship [MR/N008324/1]
  4. Leonard Wolfson Doctoral Training Fellowship in Neurodegeneration
  5. European Union (7th Framework Programme [FP7 Ideas: European Research Council]) [279062, 602102]
  6. Department of Health's NIHR Biomedical Research Centres funding scheme
  7. Epilepsy Society through the Katy Baggott Foundation
  8. Epilepsy Research UK (ERUK)
  9. Epilepsy Society, UK
  10. Associazione Italiana Contro L'Epilessia (FIRE-AICE)
  11. Fondazione Antonio Carlo Monzino
  12. National Institutes of Health (NIH) [R01 NS097719, U54 EB020403, NIH/NINDS R01 NS065838]

Ask authors/readers for more resources

The study identified elevated fractions of microglia and endothelial cells in regions of reduced cortical thickness, with differentially expressed genes showing enrichment for microglial markers, particularly activated microglial states. Findings suggest that activated microglia may play a role in cortical thinning in epilepsy.
Aims The causes of distinct patterns of reduced cortical thickness in the common human epilepsies, detectable on neuroimaging and with important clinical consequences, are unknown. We investigated the underlying mechanisms of cortical thinning using a systems-level analysis. Methods Imaging-based cortical structural maps from a large-scale epilepsy neuroimaging study were overlaid with highly spatially resolved human brain gene expression data from the Allen Human Brain Atlas. Cell-type deconvolution, differential expression analysis and cell-type enrichment analyses were used to identify differences in cell-type distribution. These differences were followed up in post-mortem brain tissue from humans with epilepsy using Iba1 immunolabelling. Furthermore, to investigate a causal effect in cortical thinning, cell-type-specific depletion was used in a murine model of acquired epilepsy. Results We identified elevated fractions of microglia and endothelial cells in regions of reduced cortical thickness. Differentially expressed genes showed enrichment for microglial markers and, in particular, activated microglial states. Analysis of post-mortem brain tissue from humans with epilepsy confirmed excess activated microglia. In the murine model, transient depletion of activated microglia during the early phase of the disease development prevented cortical thinning and neuronal cell loss in the temporal cortex. Although the development of chronic seizures was unaffected, the epileptic mice with early depletion of activated microglia did not develop deficits in a non-spatial memory test seen in epileptic mice not depleted of microglia. Conclusions These convergent data strongly implicate activated microglia in cortical thinning, representing a new dimension for concern and disease modification in the epilepsies, potentially distinct from seizure control.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available